DRUG · Unmapped registry intervention
BGB324
Find medicine records ·
Find other trials using this name
Clinical trial
Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
NCT02922777
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTrial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
BGB324DRUG
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
Texas Tech University Health Sciences Centercollaborator
BerGenBio ASAcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02922777 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.